arrow
F

Francesco Pelliccia

university sapienza
H指数:40
被引数:5,602

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Personalised antiplatelet therapy during elective percutaneous coronary intervention in patients with chronic coronary syndrome: An international journal of cardiology expert consensus statement

慢性冠状动脉综合征患者择期经皮冠状动脉介入治疗期间个体化抗血小板治疗:国际心脏病学杂志专家共识声明

2026-09-290
OA
Potentially futile outcome after uncomplicated TAVI: insights from the TRITAVI registry

经导管主动脉瓣置换术后可能无益的结局:TRITAVI注册研究中的启示

2026-05-270
PRE
Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement: The TRITAVI Registry

经导管主动脉瓣置换术后抗血小板治疗与全因死亡率:TRITAVI登记研究

2026-05-010
OAAI
Eligibility for and practical implications of Semaglutide in overweight and obese patients with acute coronary syndrome

Semaglutide在患有急性冠状动脉综合征的超重和肥胖患者中的资格和实际意义

2025-03-010
OAAI
Risk Score for Prediction of Dialysis After Transcatheter Aortic Valve Replacement
2024-04-021
OAAI
Management of high and intermediate-high risk pulmonary embolism: A position paper of the Interventional Cardiology Working Group of the Italian Society of Cardiology
2024-04-012
OAAI